glp_1 Glucagon-like peptide-1 Bariatric Fusion GLP GLP-1 Drug Side Effects May

After discontinuing its internal GLP-1 in May of 2025 for causing liver issues, Pfizer won a bidding war against seven other companies for Metsera, which is developing a variety of incretin assets, paying $10 billion in one of 2025s largest M&A deals

Dulaglutide, a modified analog of human GLP-1 covalently linked to IgG4, possesses a notably extended half-life of about 90 h, thereby expanding its therapeutic applications

KFF Health Tracking Poll May 2024: the publics use and views of GLP-1 drugs

Will you contact my insurance company

When GLP-1 RAs are not used concomitantly with a sulphonylurea or insulin, routine glucose monitoring is unnecessary due to the low risk of developing hypoglycemia